XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Cross Currency Swap [Member]
Common Stock [Member]
Cross Currency Swap [Member]
Additional Paid-in Capital [Member]
Cross Currency Swap [Member]
Treasury Stock, Common [Member]
Cross Currency Swap [Member]
Retained Earnings [Member]
Cross Currency Swap [Member]
AOCI Attributable to Parent [Member]
Cross Currency Swap [Member]
Parent [Member]
Cross Currency Swap [Member]
Noncontrolling Interest [Member]
Cross Currency Swap [Member]
Interest Rate Swap [Member]
Common Stock [Member]
Interest Rate Swap [Member]
Additional Paid-in Capital [Member]
Interest Rate Swap [Member]
Treasury Stock, Common [Member]
Interest Rate Swap [Member]
Retained Earnings [Member]
Interest Rate Swap [Member]
AOCI Attributable to Parent [Member]
Interest Rate Swap [Member]
Parent [Member]
Interest Rate Swap [Member]
Noncontrolling Interest [Member]
Interest Rate Swap [Member]
Common Stock Outstanding [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock, Common [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Parent [Member]
Noncontrolling Interest [Member]
Total
Balance (in shares) at Dec. 31, 2022                                 56,096                
Balance in Accumulated other comprehensive income (loss) beginning of period at Dec. 31, 2022                                   $ 56 $ 1,259,072 $ (17,964) $ 623,907 $ 2,500 $ 1,867,571 $ 153,404 $ 2,020,975
Stock-based compensation                                   0 2,990 0 0 0 2,990 0 2,990
Exercise of stock-based awards by employees and directors (*) (in shares) [1]                                 0                
Exercise of stock-based awards by employees and directors (*) [1]                                   0 27 0 0 0 27 0 27
Issuance of common stock (in shares)                                 3,600                
Issuance of common stock                                   4 297,117 0 0 0 297,121 0 297,121
Cash paid to noncontrolling interest                                   0 0 0 0 0 0 (2,360) (2,360)
Cash dividend declared                                   0 0 0 (6,732) 0 (6,732) 0 (6,732)
Change in noncontrolling interest                                   0 1,239 0 0 1,239 (2,396) (1,157)
Net income                                   0 0 0 29,029 0 29,029 4,235 33,264
Change in foreign currency translation adjustments                                   0 0 0 0 (306) (306) (390) (696)
Change in unrealized gains or losses in respect of the Company's share in derivative instruments of an unconsolidated investment that qualifies as a cash flow hedge                                   0 0 0 0 (1,014) (1,014) 0 (1,014)
Change in respect of derivative instruments designated for cash flow hedge $ 0 $ 0 $ 0 $ 0 $ (5,403) $ (5,403) $ 0 $ (5,403)               $ 0                  
Other                                   0 0 0 0 14 14 0 14
Balance (in shares) at Mar. 31, 2023                                 59,696                
Balance in Accumulated other comprehensive income (loss) end of period at Mar. 31, 2023                                   60 1,560,445 (17,964) 646,204 (4,209) 2,184,536 152,493 2,337,029
Balance (in shares) at Dec. 31, 2023                                 60,359                
Balance in Accumulated other comprehensive income (loss) beginning of period at Dec. 31, 2023                                   60 1,614,769 (17,964) 719,894 (1,332) 2,315,427 125,560 2,440,987
Stock-based compensation                                   0 4,769 0 0 0 4,769 0 4,769
Exercise of stock-based awards by employees and directors (*) (in shares)                                 63                
Exercise of stock-based awards by employees and directors (*)                                   0 55 0 0 0 55 0 55
Cash paid to noncontrolling interest                                   0 0 0 0 0 0 (2,587) (2,587)
Cash dividend declared                                   0 0 0 (7,243) 0 (7,243) 0 (7,243)
Net income                                   0 0 0 38,587 0 38,587 1,924 40,511
Change in foreign currency translation adjustments                                   0 0 0 0 (1,701) (1,701) (462) (2,163)
Change in unrealized gains or losses in respect of the Company's share in derivative instruments of an unconsolidated investment that qualifies as a cash flow hedge                                   0 0 0 0 510 510 0 510
Change in respect of derivative instruments designated for cash flow hedge $ 0 $ 0 $ 0 $ 0 $ 561 $ 561 $ 0 $ 561 $ 0 $ 0 $ 0 $ 0 $ 1,066 $ 1,066 $ 0 $ 1,066                  
Other                                   0 0 0 0 53 53 0 53
Balance (in shares) at Mar. 31, 2024                                 60,422                
Balance in Accumulated other comprehensive income (loss) end of period at Mar. 31, 2024                                   $ 60 $ 1,619,594 $ (17,964) $ 751,118 $ (723) $ 2,352,084 $ 124,435 $ 2,476,519
[1] Resulted in an amount lower than $1 thousand.